i
CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : Maine
-
12/21/17
-
[PDF-276.64 KB]
Details:
-
Corporate Authors:
-
Description:$422,617 Funding for AR Activities Fiscal Year 2017
Funding to local health departments:
$385,678 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections. With 2016 funding, Maine’s HAI/AR program partnered with the state public health lab to test 395 isolates using whole genome sequencing, with the goal of identifying novel resistance mechanisms and local patterns of resistance. This data can inform preparedness and containment activities to prevent HAIs.
$36,939 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. Maine implemented whole genome sequencing of Listeria, Salmonella, Campylobacter and E. coli isolates submitted $36,939 to its lab and began uploading sequence data into PulseNet for nationwide monitoring of outbreaks and trends. In Fiscal Year 2018, Maine will begin simultaneously monitoring these isolates for resistance genes. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.
Publication date from document properties.
Maine-2017-CDC-AR-Investments.pdf
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
